The cell polarity protein Scrib functions as a tumor suppressor in liver cancer

Shweta Kapil, Bal Krishan Sharma, Mallikarjun Patil, Sawsan Elattar, Jinling Yuan, Steven X. Hou, Ravindra Bharat Kolhe, Satyanarayana Ande

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Scrib is a membrane protein that is involved in the maintenance of apical-basal cell polarity of the epithelial tissues. However, Scrib has also been shown to be mislocalized to the cytoplasm in breast and prostate cancer. Here, for the first time, we report that Scrib not only translocates to the cytoplasm but also to the nucleus in hepatocellular carcinoma (HCC) cells, and in mouse and human liver tumor samples. We demonstrate that Scrib overexpression suppresses the growth of HCC cells in vitro, and Scrib deficiency enhances liver tumor growth in vivo. At the molecular level, we have identified the existence of a positive feed-back loop between Yap1 and c-Myc in HCC cells, which Scrib disrupts by simultaneously regulating the MAPK/ERK and Hippo signaling pathways. Overall, Scrib inhibits liver cancer cell proliferation by suppressing the expression of three oncogenes, Yap1, c-Myc and cyclin D1, thereby functioning as a tumor suppressor in liver cancer.

Original languageEnglish (US)
Pages (from-to)26515-26531
Number of pages17
JournalOncotarget
Volume8
Issue number16
DOIs
StatePublished - Jan 1 2017

Fingerprint

Cell Polarity
Liver Neoplasms
Hepatocellular Carcinoma
Cytoplasm
Neoplasms
Proteins
Liver
Cyclin D1
Growth
Oncogenes
Prostatic Neoplasms
Membrane Proteins
Epithelium
Maintenance
Cell Proliferation
Breast Neoplasms

Keywords

  • ERK
  • HCC
  • Hippo signaling
  • Nuclear localization
  • Yap1

ASJC Scopus subject areas

  • Oncology

Cite this

Kapil, S., Sharma, B. K., Patil, M., Elattar, S., Yuan, J., Hou, S. X., ... Ande, S. (2017). The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget, 8(16), 26515-26531. https://doi.org/10.18632/oncotarget.15713

The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. / Kapil, Shweta; Sharma, Bal Krishan; Patil, Mallikarjun; Elattar, Sawsan; Yuan, Jinling; Hou, Steven X.; Kolhe, Ravindra Bharat; Ande, Satyanarayana.

In: Oncotarget, Vol. 8, No. 16, 01.01.2017, p. 26515-26531.

Research output: Contribution to journalArticle

Kapil, S, Sharma, BK, Patil, M, Elattar, S, Yuan, J, Hou, SX, Kolhe, RB & Ande, S 2017, 'The cell polarity protein Scrib functions as a tumor suppressor in liver cancer', Oncotarget, vol. 8, no. 16, pp. 26515-26531. https://doi.org/10.18632/oncotarget.15713
Kapil S, Sharma BK, Patil M, Elattar S, Yuan J, Hou SX et al. The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget. 2017 Jan 1;8(16):26515-26531. https://doi.org/10.18632/oncotarget.15713
Kapil, Shweta ; Sharma, Bal Krishan ; Patil, Mallikarjun ; Elattar, Sawsan ; Yuan, Jinling ; Hou, Steven X. ; Kolhe, Ravindra Bharat ; Ande, Satyanarayana. / The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. In: Oncotarget. 2017 ; Vol. 8, No. 16. pp. 26515-26531.
@article{29a638a0bf9e4b07a4496e66bd77ea00,
title = "The cell polarity protein Scrib functions as a tumor suppressor in liver cancer",
abstract = "Scrib is a membrane protein that is involved in the maintenance of apical-basal cell polarity of the epithelial tissues. However, Scrib has also been shown to be mislocalized to the cytoplasm in breast and prostate cancer. Here, for the first time, we report that Scrib not only translocates to the cytoplasm but also to the nucleus in hepatocellular carcinoma (HCC) cells, and in mouse and human liver tumor samples. We demonstrate that Scrib overexpression suppresses the growth of HCC cells in vitro, and Scrib deficiency enhances liver tumor growth in vivo. At the molecular level, we have identified the existence of a positive feed-back loop between Yap1 and c-Myc in HCC cells, which Scrib disrupts by simultaneously regulating the MAPK/ERK and Hippo signaling pathways. Overall, Scrib inhibits liver cancer cell proliferation by suppressing the expression of three oncogenes, Yap1, c-Myc and cyclin D1, thereby functioning as a tumor suppressor in liver cancer.",
keywords = "ERK, HCC, Hippo signaling, Nuclear localization, Yap1",
author = "Shweta Kapil and Sharma, {Bal Krishan} and Mallikarjun Patil and Sawsan Elattar and Jinling Yuan and Hou, {Steven X.} and Kolhe, {Ravindra Bharat} and Satyanarayana Ande",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.15713",
language = "English (US)",
volume = "8",
pages = "26515--26531",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "16",

}

TY - JOUR

T1 - The cell polarity protein Scrib functions as a tumor suppressor in liver cancer

AU - Kapil, Shweta

AU - Sharma, Bal Krishan

AU - Patil, Mallikarjun

AU - Elattar, Sawsan

AU - Yuan, Jinling

AU - Hou, Steven X.

AU - Kolhe, Ravindra Bharat

AU - Ande, Satyanarayana

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Scrib is a membrane protein that is involved in the maintenance of apical-basal cell polarity of the epithelial tissues. However, Scrib has also been shown to be mislocalized to the cytoplasm in breast and prostate cancer. Here, for the first time, we report that Scrib not only translocates to the cytoplasm but also to the nucleus in hepatocellular carcinoma (HCC) cells, and in mouse and human liver tumor samples. We demonstrate that Scrib overexpression suppresses the growth of HCC cells in vitro, and Scrib deficiency enhances liver tumor growth in vivo. At the molecular level, we have identified the existence of a positive feed-back loop between Yap1 and c-Myc in HCC cells, which Scrib disrupts by simultaneously regulating the MAPK/ERK and Hippo signaling pathways. Overall, Scrib inhibits liver cancer cell proliferation by suppressing the expression of three oncogenes, Yap1, c-Myc and cyclin D1, thereby functioning as a tumor suppressor in liver cancer.

AB - Scrib is a membrane protein that is involved in the maintenance of apical-basal cell polarity of the epithelial tissues. However, Scrib has also been shown to be mislocalized to the cytoplasm in breast and prostate cancer. Here, for the first time, we report that Scrib not only translocates to the cytoplasm but also to the nucleus in hepatocellular carcinoma (HCC) cells, and in mouse and human liver tumor samples. We demonstrate that Scrib overexpression suppresses the growth of HCC cells in vitro, and Scrib deficiency enhances liver tumor growth in vivo. At the molecular level, we have identified the existence of a positive feed-back loop between Yap1 and c-Myc in HCC cells, which Scrib disrupts by simultaneously regulating the MAPK/ERK and Hippo signaling pathways. Overall, Scrib inhibits liver cancer cell proliferation by suppressing the expression of three oncogenes, Yap1, c-Myc and cyclin D1, thereby functioning as a tumor suppressor in liver cancer.

KW - ERK

KW - HCC

KW - Hippo signaling

KW - Nuclear localization

KW - Yap1

UR - http://www.scopus.com/inward/record.url?scp=85017512880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017512880&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.15713

DO - 10.18632/oncotarget.15713

M3 - Article

AN - SCOPUS:85017512880

VL - 8

SP - 26515

EP - 26531

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 16

ER -